Brooklyn FI LLC Buys New Stake in iShares Biotechnology ETF (NASDAQ:IBB)

Brooklyn FI LLC purchased a new position in iShares Biotechnology ETF (NASDAQ:IBB) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 1,694 shares of the financial services provider’s stock, valued at approximately $244,000.

Several other hedge funds and other institutional investors have also made changes to their positions in IBB. Darwin Wealth Management LLC purchased a new position in iShares Biotechnology ETF during the 3rd quarter valued at approximately $29,000. HHM Wealth Advisors LLC increased its position in iShares Biotechnology ETF by 200.0% in the fourth quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock worth $30,000 after purchasing an additional 150 shares during the last quarter. Bradley & Co. Private Wealth Management LLC purchased a new stake in iShares Biotechnology ETF during the fourth quarter valued at $32,000. Newbridge Financial Services Group Inc. purchased a new position in shares of iShares Biotechnology ETF in the 4th quarter worth $33,000. Finally, Hager Investment Management Services LLC bought a new stake in shares of iShares Biotechnology ETF in the 4th quarter worth about $34,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 0.4 %

Shares of NASDAQ:IBB opened at $134.57 on Thursday. The company has a 50-day moving average price of $136.25 and a 200 day moving average price of $139.54. iShares Biotechnology ETF has a 12 month low of $123.60 and a 12 month high of $150.57. The company has a market cap of $6.14 billion, a price-to-earnings ratio of 27.83 and a beta of 0.77.

iShares Biotechnology ETF Increases Dividend

The business also recently announced a dividend, which will be paid on Friday, March 21st. Stockholders of record on Tuesday, March 18th will be issued a $0.1212 dividend. This is a boost from iShares Biotechnology ETF’s previous dividend of $0.06. The ex-dividend date is Tuesday, March 18th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.